Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIAT
Ratios

Cullinan Therapeutics (CGEM) Accumulated Depreciation & Amortization (2020 - 2022)

Cullinan Therapeutics has reported Accumulated Depreciation & Amortization over the past 3 years, most recently at $100000.0 for Q4 2022.

  • Quarterly results put Accumulated Depreciation & Amortization at $100000.0 for Q4 2022, changed 0.0% from a year ago — trailing twelve months through Dec 2022 was $100000.0 (changed 0.0% YoY), and the annual figure for FY2022 was $100000.0, changed 0.0%.
  • Accumulated Depreciation & Amortization for Q4 2022 was $100000.0 at Cullinan Therapeutics, roughly flat from $100000.0 in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for CGEM hit a ceiling of $179000.0 in Q4 2020 and a floor of $100000.0 in Q4 2021.
  • Median Accumulated Depreciation & Amortization over the past 3 years was $100000.0 (2021), compared with a mean of $126333.3.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: crashed 44.13% in 2021 and later changed 0.0% in 2022.
  • Cullinan Therapeutics' Accumulated Depreciation & Amortization stood at $179000.0 in 2020, then crashed by 44.13% to $100000.0 in 2021, then changed by 0.0% to $100000.0 in 2022.
  • The last three reported values for Accumulated Depreciation & Amortization were $100000.0 (Q4 2022), $100000.0 (Q4 2021), and $179000.0 (Q4 2020) per Business Quant data.